Philadelphia-based ITA Partners has launched Eviti, a technology for payers and providers that aligns prescribed cancer treatments with patients' insurance plan language at the point of prescription.
The central components of Eviti include a Web-based decision-support engine and a digital oncology treatment library. Together, these provide access to the latest, nationally accepted evidence-based treatment standards for more than 120 cancer types, while also incorporating individual insurance plan language for each patient, according to the company. It can be used as a Web-based application or as an integrated component within electronic health records software.
“Eviti is unique in that the system helps oncologists select a treatment option that is both evidence-based and compliant with each patient’s insurance plan language," Eduardo Beruff, chief executive officer and president of ITA Partners, says in a statement. "Additionally, if the physician chooses a regimen that is outside the patient’s plan language, ITA’s team of oncologists and oncology experts will facilitate a resolution with the insurance company.”
Nathan Golia is senior editor of Insurance & Technology. He joined the publication in 2010 as associate editor and covers all aspects of the nexus between insurance and information technology, including mobility, distribution, core systems, customer interaction, and risk ... View Full Bio